Diagnostic accuracy of Xpert MtB/Rif assay for pulmonary tuberculosis (ptB) and extrapulmonary tB (eptB) has not been investigated in iran. this study was aimed to assess the diagnostic accuracy of Xpert MTB/RIF assay for both PTB and EPTB. A total of 2111 clinical samples (1218 pulmonary and 838 extra-pulmonary) were collected from 16 medical centers during the study period and were analyzed for detection of ptB and eptB by both Xpert MtB/Rif assay and standard conventional methods (culture and direct smear microscopy). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of Xpert MTB/RIF assay for PTB were found to be 95.5%, 96.7%, 83.8%, and 99.1% respectively. For EPTB, the sensitivity, specificity, PPV and NPV of Xpert MTB/RIF assay counted for 76.5%, 95.9%, 62%, and 97.9% respectively. Xpert MTB/RIF assay found to be highly sensitive, specific and comparable to standard conventional methods for the diagnosis of PTB. However, the sensitivity and specificity of Xpert MTB/RIF for EPTB specimens were highly variable; thus, Xpert MTB/ Rif cannot be recommended to replace standard conventional tests for diagnosis of eptB.
different provinces of Iran were included in this study. From the collected samples, 1218 (59.2 percent) were pulmonary; bronchoalveolar lavage fluid (BAL), tracheal, sputum and 838 (40.7 percent) were extrapulmonary; urine, abscess, osteoarticular, biopsy, pericardium, cerebrospinal fluid (CSF), gastric lavage, blood, real-time fluid, and ascites.
Specimens were collected from both outpatients and inpatients with a history of cough, unintentional weight loss, and fever for more than two weeks. Specimens were either from new cases or from patients with treatment failure or relapse.
The Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran approved the study and all research was performed in accordance with the relevant guidelines. All the patients and/or their legal guardians have signed informed consent.
Microscopy examination and culture. Specimens (2.5 to 10 mL) were decontaminated using 4% sodium hydroxide (NaOH) (Petroff method) 27 . Sediments of each treated sample were used to prepare a smear for Ziehl-Neelsen and Auramine fluorochrome staining and were cultured in Löwenstein-Jensen medium 27, 28 . Only one culture isolated per study subject was considered for further analysis. Each isolate was examined regarding morphology, pigmentation, and date of growth. Bacterial isolates identified as M. tuberculosis using standard biochemical tests, including production of niacin, nitrate reduction and catalase 27 . Xpert MtB/Rif. One mL unconcentrated specimens used (without centrifuge) for Xpert MTB/RIF assay.
Specimens, firstly, homogenized with a 5% acid-alcohol buffer, a 2:1 ratio as the Cepheid Company (USA) prepared in sample reagent (SR) and then added to the Xpert MTB/RIF cartridge to do the assay in Genexpert instrument. Xpert MTB/RIF, also, uses five overlapping probes (A, B, C, D, and E) to detect five mutations in the rpoB gene that accord rifampicin resistance 2 .
Data analysis. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) with 95% confidence intervals were calculated for the Xpert MTB/RIF, using culture and direct smear microscopy as the gold standard. The summary receiver operating characteristic (SROC) curve was constructed based on a bivariate regression approach to show the level of accuracy of the Xpert MTB/RIF. The multiple regression analysis was used to shows any relationship between semi-quantitative Xpert MTB/RIF results and direct smear and culture results. All statistical analyses were performed with MedCalc (version 14.8.1, Medcalc Software). Table 1 , of 1218 pulmonary specimens, 171 were positive and 982 were negative by standard conventional methods. Likewise, of 838 extrapulmonary specimens, 49 positive and 713 were negative by standard methods. Biopsy (26.5%), abscess (20.4%) and pleural fluid (14.2%) were the most commonly involved organs for EPTB.
Results

Microbiological findings. As shown in
Xpert MtB/Rif results. M. tuberculosis was present in 204 (13.4%) of pulmonary specimens and 79 of extrapulmonary specimens (Table 1) . "Invalid, " "error, " and "no result" of Xpert MTB/RIF were excluded from the study. The proportion of Xpert MTB/RIF invalid and error cases in extrapulmonary specimens was significantly Particularly, when AUC would be between 0.8 and 1, the accuracy is relatively high. As a matter of fact, AUC was 0.96 for pulmonary specimens in this report which represented a high level of accuracy. If SROC curve was in the upper left corner it would show the best combination of sensitivity and specificity for the diagnostic test. Part "a" and "b" are representative for pulmonary and extra-pulmonary specimens, respectively. more than pulmonary specimens with Chi-squared 5.62 (p < 0.02). Comparison of false positives in pulmonary and extrapulmonary specimens have not shown meaningful difference whilst false-negative results illustrated a significant difference with Chi-squared 5.93 for two groups (p < 0.02). The percentage result for each subgroup specimen of pulmonary and extrapulmonary are showed in Table 1 . Furthermore, 22 rifampicin resistance (7.7% of positive cases) and 13 rifampicin indeterminate (4.5% of positive cases) were also indicated by Xpert MTB/RIF. Sensitivity, specificity, PPV, and NPV. The overall sensitivity, specificity, PPV and NPV of Xpert MTB/ RIF assay for PTB were found to be 95.5%, 96.7%, 83.8%, and 99.1% respectively. For EPTB, the sensitivity, specificity, PPV, and NPV of Xpert MTB/RIF assay were found to be 76.5%, 95.9%, 62%, and 97.9%, respectively. Among extrapulmonary specimens, osteoarticular and pericardial specimens have lower sensitivity rather than average EPTB sensitivity (p < 0.0001). A comparison of sensitivity between PTB and EPTB showed a significant difference with 95% and 76% respectively (p < 0.0001). With the same respect, NPV for both groups was very high, while comparison of PPV between PTB and EPTB revealed a significant difference (p < 0.0001) ( Table 1 ). The forest plot (Fig. 1) shows the sensitivity, specificity, PPV, and NPV for each group of specimens. The inter-rater agreement test for PTB and EPTB showed Xpert MTB/RIF assay has substantial agreement (kappa 0.74) and moderate agreement (kappa 0.4) with standard conventional methods, respectively. The accuracy index for PTB and EPTB was 96% and 94%, respectively.
Based on the SROC curves (Fig. 2) , the AUC for pulmonary and extrapulmonary specimens was 0.96 (95% CI: 0.94-0.97) and 0.86 (95% CI: 0.83-0.88), respectively (p < 0.0001). On Xpert MTB/RIF axis, results are categorized as 0, 1, 2, 3 and 4 which are indicated as negative, very low, low, medium and high scales, respectively. On the smear axis, results are categorized as 0, 1, 2 and 3 which are indicated as negative, 1+, 2+ and 3+ grading, respectively. On culture axis, results are categorized as 0, 1, 2, 3 and 4 which are indicated as negative, 1+, 2+, 3+ and 4+ grading, respectively. Part "a" and "b" are representative for pulmonary specimens and part "c" and "d" are representative for extra-pulmonary specimens. Regression lines showed the correlations between Xpert MTB/RIF results and culture/direct smear methods results.
